Dialyzers, dialysate, and delivery systems

Chapter 6 Dialyzers, dialysate, and delivery systems


The dialyzer is a selective filter for removing toxic or unwanted solutes from the blood. The filtration process uses a semipermeable membrane between blood flowing on one side and dialysis fluid, called dialysate, flowing on the opposite side. The delivery system prepares dialysate of correct chemical composition, and then delivers it at proper temperature and other parameters to the dialyzer.


All dialyzers consist of a series of parallel flow paths designed to provide a large surface area between blood and membrane, and membrane and dialysate. There are two basic flow path geometries: (1) rectangular cross section, seen in parallel plate dialyzers; and (2) circular cross section, seen in hollow-fiber dialyzers. Virtually all hemodialyzers in clinical use today are the hollow-fiber type; however, for historical purposes, the parallel plate and coil dialyzers will be discussed.





Hollow-fiber dialyzers


The hollow-fiber artificial kidney (HFAK) is by far the most commonly used dialyzer. HFAKs are available in a wide variety of sizes and membranes.







Membranes for hemodialysis


Membranes used in hemodialysis are of two basic types: (1) organic cellulose derivatives and (2) synthetic membranes.


Willem Kolff used cellulose sausage casings for the first successful clinical dialysis. Cellulosic membranes continue to be basic for many dialyzers. Synthetic membranes were developed in the search for efficient, large-volume seawater desalinization by reverse osmosis. The development of volume-controlled ultrafiltration equipment for hemodialysis made the use of these high-hydraulic permeability membranes practical. They, in turn, have made high-flux hemodialysis, hemofiltration, and continuous renal replacement therapy (CRRT) viable options in renal treatment.









Membrane biocompatibility


Each time blood comes in contact with a foreign surface, an inflammatory response is elicited. This response is used to gauge the biocompatibility of a hemodialysis membrane. When there is an intense reaction and a high level of inflammation, the membrane is said to be bioincompatible. When the response and inflammation are mild, the membrane is classified as biocompatible. The level of membrane biocompatibility may be associated with both short- and long-term consequences.






Which membranes induce the highest levels of complement activation?


Cellulose and cellulose-based membranes induce more complement activation than do synthetic membranes (Table 6-1). The chemical composition of the cellulosic surface is similar to that of the cell wall of bacteria: both are chains of polysaccharide structures. The body responds to blood-cellulose contact in much the same way as it does to invasion by bacteria. Free hydroxyl groups on the membrane surface are likely the primary source of the intense complement activation. Chemical alterations to buffer the free hydroxyl groups are used to create “modified cellulosic membranes,” such as cellulose acetate and Hemophan. Membranes of cellulose acetate have some of the surface hydroxyl linked with acetyl groups. Hemophan membranes have amino groups attached to the reactive sites to buffer them. Both of these modifications reduce the amount of complement generated; however, these membranes are still less effective than synthetic membranes in minimizing complement production.





What are some of the long-term considerations when selecting a membrane for hemodialysis?


Long-term use of bioincompatible membranes may be associated with an increased incidence of infection and malignancy and with impaired nutritional status. Patients dialyzed on cellulosic membranes have a higher incidence of β2-amyloid disease (β2AD) than those dialyzed on synthetic membranes. The increased risk of infection and malignancy is thought to be due to repeated attacks on the patient’s immune system. When patient blood is repeatedly exposed to bioincompatible surfaces, the body responds as though under attack. The immune system kicks in, complement is generated, and the inflammatory response is triggered. There can be tissue damage, and future stimuli may elicit only a limited response, thus predisposing the individual to infection and potential malignancy.


Malnutrition is a major contributor to morbidity and mortality of patients on hemodialysis. Even with adequate protein intake, malnutrition is a problem and seems to relate to an accelerated catabolic process, most evident on dialysis days. A catabolic effect associated with bioincompatible membrane is well documented. However, recent studies have demonstrated an increase in protein catabolism during hemodialysis with synthetic membranes as well (Ikizler et al., 2002). β2AD is important in long-term morbidity. Clinical manifestations include arthropathies, bone lesions and pathologic fractures, soft tissue swelling, and carpal tunnel syndrome. Patients being dialyzed with cellulosic bioincompatible membranes exhibit more pronounced clinical symptoms of amyloidosis (Schiffl et al., 2000). Possible reasons for the difference include the following:




< div class='tao-gold-member'>

Stay updated, free articles. Join our Telegram channel

Jul 24, 2016 | Posted by in NURSING | Comments Off on Dialyzers, dialysate, and delivery systems

Full access? Get Clinical Tree

Get Clinical Tree app for offline access